急性肺损伤和心脏骤停后综合征:一个叙述性回顾
Yusuke Endo1, Tomoaki Aoki1, Daniel Jafari2
1Laboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, USA.
Journal of intensive care
|September 3, 2024
概括
心脏骤停后的肺损伤 (PALI) 显著影响心脏骤停后的结果. 本综述强调了肺保护性通风,低温和用于PALI管理的新型线粒体疗法.
科学领域:
- 关键护理医学 关键护理医学
- 肺部医学 肺部医学
- 心脏病学 心脏病学
背景情况:
- 心脏骤停后综合征 (PCAS) 涉及严重的神经损伤和高死亡率.
- 停顿后肺损伤 (PALI) 是PCAS的一个关键并发症,恶化了患者的结果.
- 帕利病原包括胸部压缩创伤,肺缺血-再输液,吸血和全身炎症.
研究的目的:
- 审查病理病理生理学,流行病学和治疗策略,以治疗停顿后肺损伤 (PALI).
- 综合目前关于PALI的知识,为临床实践和未来研究提供信息.
主要方法:
- 对PALI的临床前和临床研究进行了全面的文献搜索.
- 综合数据,提供PALI流行病学,病理生理学和管理的概述.
主要成果:
- 帕利会影响到50%的心脏骤停幸存者.
- 诊断成像 (CXR,CT,超声波) 有助于PALI的识别和严重程度的评估.
- 肺部保护性通风,治疗性低温和线粒体疗法对PALI管理有希望.
结论:
- 在心脏骤停后的护理中,PALI是一个主要的临床挑战.
- 及时诊断和有针对性的干预措施,包括新的线粒体疗法,对于改善结果至关重要.
- 需要进一步的研究来优化PALI管理和心脏骤停后的护理.
相关概念视频
Acute Respiratory Failure-II
186
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
186
Acute Respiratory Failure-I
179
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
179
Acute Respiratory Failure-V
125
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
125
Acute Respiratory Failure-IV
131
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
131
Acute Respiratory Failure-III
163
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
163


